semaglutide news november 28 2025 Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch States retreat from covering drugs

The tentative nod confirms that Apotexs generic semaglutide meets the FDAs standards for quality, safety and efficacy

Nutritional Psychology Research Library (NPRL)

Is there an increased risk of bowel cancer in patients taking semaglutide for type 2 diabetes or obesity, especially those with a family history of bowel cancer or previous gastrointestinal issues?

Here we report the design and preclinical evaluation of a unimolecular quintuple agonist, which via covalent binding of Lani to a GLP-1RGIPR co-agonist allows for its targeted delivery into cells that express the receptor for GLP-1 or GIP

10.1038/s41467-024-47972-4 32 DeaconC

Discontinue Rybelsus in women at least 2 months before a planned pregnancy due to the long washout period for Semaglutide